These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 12885688

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
    Lee RW, Lindstrom ST.
    Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
    Griffin AT, Peyrani P, Wiemken T, Arnold F.
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
    McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN.
    Arch Intern Med; 2009 Sep 14; 169(16):1525-31. PubMed ID: 19752411
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC, Ioachimescu AG, Iannini PB.
    Int J Antimicrob Agents; 2004 Nov 14; 24(5):485-90. PubMed ID: 15519482
    [Abstract] [Full Text] [Related]

  • 16. Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population.
    Murcia JM, González-Comeche J, Marín A, Barberán J, Granizo JJ, Aguilar L, González-Moreno J, González-Pina B, López-Dupla M, Irurzun J, SCAPE Study Group.
    Clin Microbiol Infect; 2009 Nov 14; 15(11):1046-50. PubMed ID: 19548926
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG.
    Arch Intern Med; 2004 Mar 22; 164(6):637-44. PubMed ID: 15037492
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.